EHS-COVID (290) Home care of patients with COVID-19 (2) Evidence informed standardised prescription: home care for mild COVID

13 May, 2021

A vast majority of those with COVID have mild to moderate symptoms - and can appropriately be managed at home. In most cases people seek care from registered medical practitioners. But many clinicians and consultants are prescribing a cocktail of drugs which are known to have little or no value in improvement of patients. On the other hand it adds unnecessarily to costs, causes anxiety and makes diagnosis of progressive symptoms difficult (progression of disease, complication or drug reactions). To help clinicians tide over and have a tool which is backed by evidence, the evidence-informed standardised prescription has been developed for modern medicine doctors treating mild or moderate COVID cases at home (in-person or telemedicine).

Access is free but restricted to only modern medicine doctors (anywhere in the world) and organisations on a peer-to-peer basis . More details are available here

Dr. Soumyadeep Bhaumik

Recent Pubs:

Trans Royal Soc of Trop Med Hygiene: Prevention, control and management of leptospirosis in India: an evidence gap map

PloS Neg Trop Dis: Interventions for the management of snakebite envenoming: An overview of systematic reviews

Please use official e-mail ID for correspondence regarding The George Institute for Global Health, India

HIFA profile: Soumyadeep Bhaumik was the HIFA Country Representative of the Year for 2012, and is a medical doctor from India working in the field of evidence syntheses. He has previously worked as a Senior Research Scientist at the South Asian Cochrane Network and Centre, India and as a Biomedical Genomics Fellow in BioMedical Genomics Centre, Kolkata. He has also consulted for evidence synthesis projects for Evidence Aid, Oxford UK and Public Health Foundation of India.He currently studies international public health in the Liverpool School of Tropical Medicine. In addition he has experience in science and research communication and has written for British Medical Journal, Canadian Medical Association Journal, Lancet and Lancet Oncology and National Medical Journal of India. Soumyadeep is a member of the HIFA working group on Evidence-Informed Policy and Practice. drsoumyadeepbhaumik AT